Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Randomized Placebo-controlled Trial
100%
Spinal Cord Injury
100%
Neuropathic Pain
100%
Ultramicronized Palmitoylethanolamide
100%
Palmitoylethanolamide
100%
Spasticity
50%
Placebo
33%
Add-on Therapy
33%
Pain Intensity
33%
Non-associated
16%
Inflammation
16%
Pain Reduction
16%
Adverse Effects
16%
Placebo-controlled
16%
Primary Outcome Measure
16%
Efficacy Analysis
16%
Randomized Double-blind
16%
Intention-to-treat
16%
Pain Score
16%
Change in Mean
16%
Baseline Period
16%
Placebo Treatment
16%
Sleep Problems
16%
Endocannabinoids
16%
Evoked Pain
16%
Protocol Compliance
16%
Insomnia
16%
Psychological Functioning
16%
Numeric Rating Scale
16%
Patient Global Impression of Change
16%
Fatty Acid Amides
16%
Pain Diary
16%
Baseline Observation Carried Forward
16%
Means Reduction
16%
Anxiety-depressive Disorders
16%
Per-protocol Analysis
16%
Difference in Means
16%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Spinal Cord Injury
100%
Neuropathic Pain
100%
Palmitoylethanolamide
100%
Spasticity
37%
Add on Therapy
25%
Inflammation
12%
Fatty Acid
12%
Carboxamide
12%
Endocannabinoid
12%
Adverse Effect
12%
Neuroscience
Placebo
100%
Neuropathic Pain
100%
Spinal Cord Injury
100%
Endocannabinoid
20%
Fatty Acid Amides
20%
Adverse Effect
20%